Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

NULL
   
  • Closing Price Chg:
    -30.00p
  • 52 Week High: NULL
  • 52 Week Low: 1,424.00p
  • Currency: UK Pounds
  • Shares Issued: 66.04m
  • Volume: 0
  • RiskGrade: 128

Company Listing Data

EPIC GNS
Sector Pharma and Biotech
ISIN GB0002074580
Market Sector MAIN
Market Segment STMM
Main Indices techMARK, FTSE 250, FTSE 350, FTSE All-Share, FTSE techMARK Focus
Country of register Great Britain
Currency British Pound
Market Cap £0m
NMS 500
Shares in issue 66.04m
Date Listed 02-Dec-2005

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price NULL
Closing Price Change -30.00p
% Change 0.00 %
52 Week High NULL
52 Week Low 1,424.00p
Volume 0
Shares Issued 66.04m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.41% below the market average92.41% below the market average92.41% below the market average92.41% below the market average92.41% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
68.43% above the market average68.43% above the market average68.43% above the market average68.43% above the market average68.43% above the market average
91.11% above the sector average91.11% above the sector average91.11% above the sector average91.11% above the sector average91.11% above the sector average
Income
98.32% below the market average98.32% below the market average98.32% below the market average98.32% below the market average98.32% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.96% below the market average91.96% below the market average91.96% below the market average91.96% below the market average91.96% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 6
Buy 2
Neutral 0
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 06-Mar-25 07-Nov-24
Paid 04-Apr-25 06-Dec-24
Amount 10.30p 21.70p

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Genus Key Personnel

CEO Jorgen Kokke

Top of Page